Benefits of Diabetes Support Group in Chronic Disease Management Program (Prolanis) in Puskesmas Jetis II, Bantul District: a Case Study

Yulia Dewi Irawati(1*), Adi Heru Sutomo(2), Mora Claramita(3)

(1) Puskesmas Jetis II; Bantul; Yogyakarta; Indonesia
(2) Department of Family and Community Medicine; Faculty of Medicine, Public Health and Nursing; Universitas Gadjah Mada; Indonesia
(3) Department of Medical, Health Professions Education and Bioethics; Faculty of Medicine, Public Health and Nursing; Universitas Gadjah Mada; Indonesia
(*) Corresponding Author


Background: Type 2 diabetes mellitus is a chronic disease and has the potential for complications that affect the entire body so that it requires a comprehensive approach. This means that the management of DMT2 must involve various parties, both medical, paramedic, patient, family and community. One strategy for managing DMT2 is Prolanis (Chronic Disease Management Program) which is a diabetes support group at Jetis II Health Center. To find out the success of Prolanis implementation, an evaluation of the benefits of the diabetes support group is needed. Objective: To find out the benefits obtained from participating in the diabetes support group in Prolanis at the Jetis II Bantul Health Center. Method: A qualitative descriptive study with a case study approach. Data were obtained from patients with DMT2 members of Prolanis (Chronic Disease Management Program) and officers of the Jetis II health center in Bantul Regency. Retrieval of data in patients with focus group discussions on 30 resource persons divided into 3 groups. Other data is by conducting independent interviews with 6 informants of the puskesmas staff involved in the diabetes support group activities of Prolanis. Results: The benefits obtained from the diabetes support group are grouped into 3 categories namely biopsychosocial support, information, and individual empowerment. Most patients benefit from obtaining biopsychosocial support from the Prolanis group. Benefits for DMT2 patients Prolanis members get information in the second place and the last is individual empowerment at least the benefits are felt. Conclusion: The benefits of a diabetes support group for DMT2 patients in Prolanis members are to get biopsychosocial support, information, and individual empowerment.


type 2 diabetes mellitus; diabetes support group; prolanis; puskesmas

Full Text:



1. World Health Organization. Global report on diabetes. Geneva: World Health Organization. 2016.

2. International Diabetes Federation/IDF. IDF diabetes atlas. 4th edition, IDF, Brossels, Belgium. 2016.

3. World Health Organization. Chronic disease are the major cause of death and disability Worldwide. Geneva: Facing The Fact World Health Organization. 2002.

4. Riskesdas. Riset kesehatan dasar. Basic health research. Health Research and Development Agency of the Indonesian Ministry of Health. Jakarta: Litbangkes Agency, Depkes RI. 2013.

5. Bantul District Health Office. Bantul District Health Profile 2017. Bantul: Bantul District Health Office. 2017.

6. Soegondo S, Soewondo P, Subekti I. Integrated diabetes management. Jakarta: Faculty of Medicine, Universitas Indonesia. 2007.

7. Paul S, Charura D. 12 The relationship in group therapy. The therapeutic relationship handbook: Theory and practice. 2014 Oct 1;1(1):131.

8. Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Fischl AH, Maryniuk MD, Siminerio L, Vivian E. Diabetes self-management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. The Diabetes Educator. 2017 Feb;43(1):40-53.

9. McWhinney IR, Freeman T. Textbook of family medicine. Oxford University Press. 2009.

10. Hermansyah, A. & Yulistika, D. Evaluation of Prolanis activities in the Work Area of North Purwokerto I Health Center, Banyumas Regency in 2016 [Thesis] (not published). Surakarta: Faculty of Health Sciences, Muhammadiyah University Purwakarta. 2016.

11. BPJS. Practical Guide: Prolanis (Chronic Disease Management Program). Jakarta: BPJS Health. 2014.

12. Tang TS, Funnell MM, Oh M. Peer reviewed: Lasting effects of a 2-year diabetes self-management support intervention: Outcomes at 1-year follow-up. Preventing Chronic Disease. 2012;9.

13. Izzah Z, Suprapti B, Aryani T, Budiatin AS, Rohmadi M, etc. Support groups for diabetes improve compliance and control of patients’ blood glucose levels. Indonesian Clinical Pharmacy Journal. 2013;2(3):94-101.

14. Moleong LJ. Qualitative research methodology. Bandung: Remaja Rosdakarya. 2011.

15. Sugiyono. Quantitative, qualitative research methods and R & D. Bandung: Alfabeta. 2009.

16. Soegondo S, Soewondo P, Subekti I. Integrated diabetes management. Jakarta: Faculty of Medicine, Universitas Indonesia. 2007.

17. Zrebiec J. Tips for running a successful group. Diabetes Spectrum. 2003 Apr 1;16(2):108-11.

18. Brundisini F, Vanstone M, Hulan D, DeJean D, Giacomini M. Type 2 diabetes patients’ and providers’ differing perspectives on medication nonadherence: A qualitative meta-synthesis. BMC Health Services Research. 2015 Jun;15(1):516.

19. Sachmechi I, Wang A, Kim P, Reich D, Payne H, Salvador VB. Impact of diabetes education and peer support group on the metabolic parameters of patients with diabetes mellitus (type 1 and type 2). British Journal of Medical Practitioners. 2013 Dec 1;6(4):10-5.

20. Nair KM, Levine MA, Lohfeld LH, Gerstein HC. “I take what I think works for me”: A qualitative study to explore the patient perception of diabetes treatment benefits and risks. Journal of Population Therapeutics and Clinical Pharmacology. 2007;14(2).

21. Aswathy S, Unnikrishnan AG, Kalra S, Leelamoni K. Peer support as a strategy for effective management of diabetes in India. Indian Journal of Endocrinology and Metabolism. 2013 Jan;17(1):5.

22. Mola E, Eriksson T, Allen J, Gay B, Crebolder H, Catholic J. The European definition of general practice/family medicine. WONCA EUROPE. 2011.


Article Metrics

Abstract views : 1778 | views : 1644


  • There are currently no refbacks.

Copyright (c) 2019 Yulia Dewi Irawati, Adi Heru Sutomo, Mora Claramita

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

View My Stats